her2 breast cancer: managing patients on t-dm1
Published 5 years ago • 2.7K plays • Length 6:40Download video MP4
Download video MP3
Similar videos
-
3:51
adjuvant t-dm1 therapy for early-stage her2 breast cancer
-
7:45
trastuzumab emtansine in her2 breast cancer
-
1:36
phase 3 trial investigates t-dm1 and pertuzumab in her2 breast cancer
-
3:48
neoadjuvant t-dm1 in early-stage her2 breast cancer
-
3:21
how breast cancer treatment kadcyla (t-dm1) works
-
5:15
case review: t-dm1 for residual her2 breast cancer
-
2:02
dr. pegram on early treatment with t-dm1
-
47:29
optimizing therapy in her2 disease with dr. reshma mahtani
-
1:14
dr. cheng on the role of t-dm1 in her2 breast cancer
-
1:55
benefit of antibody drug conjugate t-dm1 in her2 bc
-
0:56
t-dm1 as part of our standard of care with residual her 2 disease
-
6:53
treating early her2 breast cancer: katherine
-
9:38
role of t-dm1 in her2-positive metastatic breast cancer
-
4:52
emilia trial: t-dm1 in metastatic breast cancer
-
49:25
optimizing therapy in her2 disease with dr. hope s. rugo
-
1:31
current treatment options for patients with her2-positive metastatic breast cancer
-
4:04
neoadjuvant t-dm1 in her2 early breast cancer
-
4:33
upfront t-dm1 in her2-positive breast cancer
-
3:22
managing recurrent metastatic er /her2- breast cancer